All inflammatory bowel disease articles
-
NewsGut bacteria and inflammatory bowel disease: a new frontier in treatment
A new review highlights the therapeutic potential of various prebiotics derived from different food sources for manipulating gut bacteria.
-
NewsCryptic genetic element in the human gut could double as sensitive biomarker
A study shows that a mysterious plasmid that is highly prevalent in the human gastrointestinal tract could be used to identify faecal contamination and offer insights into the severity of intestinal diseases.
-
NewsStudy reveals possible triggers for inflammatory bowel disease
A new study finds a complex interplay between diet, genes, and the gut microbiota that could explain why IBD develops.
-
NewsResearchers call for regulation of direct-to-consumer microbiome tests
Scientists argue that direct-to-consumer (DTC) microbiome tests lack analytical and clinical validity and require more federal regulation to prevent consumer harm.
-
NewsReverse metabolomics method finds biomarker for inflammatory bowel disease
Scientists develop a groundbreaking approach to microbiome research, improving its ability to explain and treat disease.
-
NewsEarly life exposure to broccoli sprouts protects against colitis in IBD
High fiber diets, like those that include broccoli sprouts or other cruciferous vegetables, may reduce disease symptoms and improve quality of life in patients with inflammatory bowel disease (IBD), according to a study conducted in mice.
-
NewsGut microbiota-derived 7-DHC tackles circadian rhythm disorders and IBD
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract categorized into ulcerative colitis and Crohn’s disease. Currently, aminosalicylates, glucocorticoids, immunomodulating drugs, and biological agents are common strategies for the treatment of IBD. The efficacy of these therapies is limited, however, and they are ...
-
NewsOral lipid nanoparticle drug can prevent development of colitis-associated cancer
An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University. The findings published in the journal Pharmaceutics report the ...
-
NewsResearcher’s work on silent flagellins earns major award
Sara Clasen, a postdoctoral fellow in the Institute for Biomedical Sciences at Georgia State University, is the grand prize winner of the prestigious 2023 NOSTER & Science Microbiome Prize.
-
NewsNew research reveals gut microbiota link to colitis - and therapetic strategies
Researchers have revealed a new and critical role of Axin1 in regulating intestinal epithelial development and microbial homeostasis.
-
NewsChild IBD risk linked to antibiotics and diet
Children and adolescents face greater risk of inflammatory bowel disease (IBD) when exposed to antibiotics or a Western diet at early ages, or when their family has higher socioeconomic status, according to a study being presented today at Digestive Disease Week® (DDW) 2023. “Pediatric IBD cases are ...
-
NewsTwo new bacterial species identified from patients with inflammatory bowel disease
Investigators at University Medical Center Utrecht and Yale University have isolated and characterized two new bacterial species from patients with inflammatory bowel disease (IBD).
-
NewsNew research unit awarded €6m to investigate gut-brain axis
The German Research Foundation (DFG) is funding a new clinical research unit that will investigate the interaction between the digestive and nervous systems with reference to inflammatory and degenerative diseases, the first collaborative research group in Germany to explore the “gut-brain axis”.
-
NewsProbiotic ‘backpacks’ could treat inflammatory bowel diseases
Researchers have devised specialised nano-particles that can neutralise molecules linked to inflammatory bowel disease (IBD), and can be attached to beneficial probiotic bacteria targeting the gut.
